Building Clientele for Advertising and EventsResponsible for delivering impactful Strategy for client brands. Offering a seamless Full service integrated Marketing experience to clients through service lines and Collaborations with reputed partners.

Head marketing for a 200 Cr portfolio in Diabetes. Consistently hit Top and Bottom line performance

Managing 3 Divisions in Dermatology, Dermatologicals, Dermo-Cosmetics and Avene in association with PFDC France.

Launched and Established Primalands Division- Rs. 370 mio SBU (97% performance) with double digit growth in 2 years with emphasis on Medico-marketing strategies and team development

Croslands Division leading the Acne segment. Revived Minoz (Minocycline)– Rs. 110 mio from decline to growth of 12%- No 1 brand. Managed 3 Advisory Boards- Acne Forum, Fungal Study Group, Dermatrends Launched Lulifin (Luliconazole ) in-licensed brand of Sumitomo Japan. No1 launch in Dermatology category. Promoted as Group Product Manager

Handled preventive medications- Vaccines. Launched India's 1st Virosomal based Hepatitis A Vaccine in collaboration with Crucell. Gained 11 % Market Share in year1 from market leader GSK

Exposure to Acute therapy area Antibiotics, Muscle relaxants. Handled a Mass Antibiotic- Fixx (Cefixime) and antibiotic for serious bacterial infection Linox (Linezolid). Managed Co Promotion of brands in 2 divisions and drove double digit growth through separate indication focus. Was chosen to lead the launch of in-licensed Eisai brand Epry (Eperisone) in India and made a successful impact in 1st year. Was coached by few of the best marketing brains in the pharmaceutical industry

Handled Clinical Dermatology Portfolio and was given independent charge of top brands of the division. Lead a turnaround performance through core brand prescriber base increase and portfolio augmentation. Promoted from Product executive to Product manager